Table 2.
Autoantibody survey of leprosy in research participants at a family health unity in Marabá, Pará
| Autoantibody | n | % |
|---|---|---|
| ANA HEp-2 | 6 | 14.6 |
| Reagent (AC-2) | 1 | 2.4 |
| Reagent (AC-4) | 4 | 9.8 |
| Reagent (AC-4/AC-20) | 1 | 2.4 |
| Non-Reactive | 35 | 85.4 |
| Anti-cardiolipin IgG (aCL) | ||
| Positive (> 15 GPL) | 1 | 2.4 |
| Negative (< 15 GPL) | 40 | 97.6 |
| Anti -β2 glycoprotein IgG (U/mL) | ||
| Positive (> 5.0 U/mL) | 2 | 4.9 |
| Negative (< 5.0 U/mL) | 39 | 95.1 |
| Anti -β2 glycoprotein IgM (U/mL) | ||
| Positive (> 5.0 U/mL) | 6 | 14.6 |
| Negative (< 5.0 U/mL) | 35 | 85.4 |
| Rheumatoid Factor | ||
| Positive (> 14.0 IU/mL) | 1 | 2.4 |
| Negative (< 14.0 IU/mL) | 40 | 97.6 |
ANA: anti-cell autoantibodies